|
 |
|
MedTRACK is the leading on-line Research Tool for Biomedical Intelligence and monitors
every significant development by examining both Financial and Pipeline data.
Among the analyses featured are the Top companies and other statistics based on different categories.
Key Lists
 Top 10 Public Pharmaceutical Companies by Market Value ($ In millions)
| Company Name |
Symbol |
Share Price |
Mkt.Value |
SPC1M (%) |
| Johnson & Johnson |
JNJ |
57.83 |
159485.5402 |
-2.08 |
| Pfizer Inc |
PFE |
15.09 |
121717.9592 |
5.82 |
| F. Hoffmann-La Roche Ltd |
ROG |
136.30 |
112972.6485 |
-8.58 |
| Novartis AG |
NOVN |
49.09 |
112313.011 |
1.59 |
| Merck & Co Inc |
MRK |
35.06 |
109304.5237 |
0.26 |
| GlaxoSmithKline plc |
GSK |
11.22 |
90910.649 |
-1.88 |
| Abbott Laboratories |
ABT |
48.98 |
75603.8166 |
4.70 |
| AstraZeneca Plc |
AZN |
50.60 |
73319.4 |
7.36 |
| Novo Nordisk A/S |
NOVO B |
487.40 |
50318.4793 |
-1.36 |
| Bayer Ag |
BAY |
44.50 |
48155.8625 |
-3.05 |
| *SPC1M - Share Price Change in 1 month (%) | ^Top |
Top 10 Public Biotech Companies by Market Value ($ In millions)
| Company Name |
Symbol |
Share Price |
Mkt.Value |
SPC1M (%) |
| F. Hoffmann-La Roche Ltd |
ROG |
136.30 |
112972.6485 |
-8.58 |
| GlaxoSmithKline plc |
GSK |
11.22 |
90910.649 |
-1.88 |
| Ossur hf. |
OSSR |
196.50 |
89158.3396 |
7.38 |
| Novo Nordisk A/S |
NOVO B |
487.40 |
50318.4793 |
-1.36 |
| Bayer Ag |
BAY |
44.50 |
48155.8625 |
-3.05 |
| Takeda Pharmaceutical Company Limited |
Stock Code Number : 4502 |
3,980.00 |
36170.8109 |
4.19 |
| Reckitt Benckiser Group plc. |
RB. |
31.81 |
35754.6663 |
1.56 |
| Japan Tobacco Inc. |
Stock Code Number : 2914 |
287,000.00 |
31654.8535 |
3.35 |
| Merck KGaA |
MRK |
66.97 |
19052.4022 |
11.47 |
| Genzyme Corporation |
GENZ |
69.79 |
18624.761 |
37.46 |
| *SPC1M - Share Price Change in 1 month (%) | ^Top |
Top 10 Public Biotech Startup Companies by Market Value ($ In millions)
| Company Name |
Symbol |
Share Price |
Mkt.Value |
SPC1M (%) |
| Onyx Pharmaceuticals Inc |
ONXX |
25.61 |
1604.1017 |
18.62 |
| Momenta Pharmaceuticals Inc |
MNTA |
21.02 |
943.4196 |
71.45 |
| Allos Therapeutics Inc |
ALTH |
4.86 |
509.631 |
-20.72 |
| Ardea Biosciences, Inc. |
RDEA |
19.50 |
444.1763 |
-5.16 |
| SIGA Technologies Inc |
SIGA |
8.28 |
360.7905 |
7.53 |
| Pharmacyclics Inc |
PCYC |
6.88 |
351.2399 |
3.30 |
| Ariad Pharmaceuticals Inc |
ARIA |
3.22 |
351.1178 |
14.18 |
| Immunosyn Corporation |
IMYN |
1.21 |
323.7388 |
-12.32 |
| PROLOR Biotech, Inc. |
PBTH |
5.58 |
257.676 |
-19.01 |
| BioCryst Pharmaceuticals Inc |
BCRX |
5.79 |
254.8295 |
-2.03 |
| *SPC1M - Share Price Change in 1 month (%) | ^Top |
Top 20 Public Companies By Sales ($ in millions)
| Company Name |
Symbol |
Share Price |
SalesValue |
SPC1M (%) |
| CAPS Holdings Limited |
CAPS |
0.01 |
3568967.6451 |
-9.09 |
| Japan Tobacco Inc. |
Stock Code Number : 2914 |
287,000.00 |
65651.052 |
3.35 |
| Johnson & Johnson |
JNJ |
57.83 |
62502 |
-2.08 |
| Pfizer Inc |
PFE |
15.09 |
55892 |
5.82 |
| F. Hoffmann-La Roche Ltd |
ROG |
136.30 |
47225.6365 |
-8.58 |
| Novartis AG |
NOVN |
49.09 |
46689 |
1.59 |
| GlaxoSmithKline plc |
GSK |
11.22 |
45309.1442 |
-1.88 |
| Bayer Ag |
BAY |
44.50 |
44029.8317 |
-3.05 |
| AstraZeneca Plc |
AZN |
50.60 |
33679 |
7.36 |
| Merck & Co Inc |
MRK |
35.06 |
33465.3 |
0.26 |
| Abbott Laboratories |
ABT |
48.98 |
31744.693 |
4.70 |
| Celesio AG |
CLS1 |
17.80 |
30733.0706 |
-1.33 |
| Kirin Holdings Company, Limited |
Stock Code Number : 2503 |
1,170.00 |
23906.9249 |
4.28 |
| Eli Lilly & Co |
LLY |
35.45 |
22274.5 |
5.82 |
| Bristol-Myers Squibb Company |
BMY |
25.08 |
19293 |
0.56 |
| Takeda Pharmaceutical Company Limited |
Stock Code Number : 4502 |
3,980.00 |
15662.027 |
4.19 |
| Toray Industries, Inc. |
Stock Code Number : 3402 |
465.00 |
14550.2271 |
8.64 |
| Teva Pharmaceutical Industries Ltd |
TEVA |
47.17 |
14405 |
-9.27 |
| Ajinomoto Co., Inc. |
Stock Code Number : 2802 |
834.00 |
12394.4647 |
3.35 |
| Reckitt Benckiser Group plc. |
RB. |
31.81 |
12131.5719 |
1.56 |
^Top
Top 20 Public Companies by R&D($ in millions) Spending
| Company Name |
Symbol |
R&D |
| F. Hoffmann-La Roche Ltd |
ROG |
8,730 |
| Pfizer Inc |
PFE |
7,754 |
| Novartis AG |
NOVN |
7,469 |
| Johnson & Johnson |
JNJ |
6,986 |
| Sanofi-aventis |
SAN |
6,388 |
| GlaxoSmithKline plc |
GSK |
5,866 |
| Merck & Co Inc |
MRK |
5,613 |
| Eli Lilly & Co |
LLY |
4,327 |
| AstraZeneca Plc |
AZN |
4,241 |
| Bayer Ag |
BAY |
3,827 |
| Bristol-Myers Squibb Company |
BMY |
3,647 |
| Amgen Inc. |
AMGN |
2,858 |
| Abbott Laboratories |
ABT |
2,744 |
| Daiichi Sankyo Company, Limited |
Stock Code Number : 4568 |
2,122 |
| Astellas Pharma Inc. |
Stock Code Number : 4503 |
2,108 |
| BASF SE |
BAS |
1,949 |
| Merck KGaA |
MRK |
1,874 |
| Eisai Co., Ltd. |
Stock Code Number : 4523 |
1,673 |
| The Dow Chemical Company |
DOW |
1,492 |
| Novo Nordisk A/S |
NOVO B |
1,472 |
^Top
Top 20 Public Companies by Number of Employees
| Company Name |
Symbol |
No. of Employees |
| Johnson & Johnson |
JNJ |
115,500 |
| Pfizer Inc |
PFE |
113,800 |
| Bayer Ag |
BAY |
107,800 |
| GlaxoSmithKline plc |
GSK |
100,000 |
| Merck & Co Inc |
MRK |
100,000 |
| Novartis AG |
NOVN |
100,000 |
| F. Hoffmann-La Roche Ltd |
ROG |
81,507 |
| Abbott Laboratories |
ABT |
73,000 |
| AstraZeneca Plc |
AZN |
62,700 |
| Celesio AG |
CLS1 |
46,968 |
| Eli Lilly & Co |
LLY |
40,360 |
| Teva Pharmaceutical Industries Ltd |
TEVA |
35,089 |
| Merck KGaA |
MRK |
33,603 |
| Novo Nordisk A/S |
NOVO B |
28,809 |
| Bristol-Myers Squibb Company |
BMY |
28,000 |
| Reckitt Benckiser Group plc. |
RB. |
24,900 |
| Royal DSM N.V. |
DSM |
22,738 |
| Takeda Pharmaceutical Company Limited |
Stock Code Number : 4502 |
19,362 |
| Mylan, Inc. |
MYL |
15,500 |
| HalcyGen |
HGN |
14,000 |
^Top
Top Mergers and Acquisitions for 2009
| Acquirer |
Target |
M&A Date |
M&A Price in $millions |
| Sanofi-Aventis S.A. (SAN) |
Merial Limited |
September 18, 2009 |
4,000 |
| CSL Limited (CSL) |
Talecris Biotherapeutics Holdings Corp. (TLCR) |
June 09, 2009 |
3,100 |
| Watson Pharmaceuticals, Inc. (WPI) |
Robin Hood Holdings Limited (Arrow Group) |
December 02, 2009 |
1,750 |
| Sandoz International GmbH |
EBEWE Pharma Ges.m.b.H Nfg.KG - Specialty Generic Injectables Business |
September 24, 2009 |
1,257 |
| Astellas Pharma, Inc. (4503) |
CV Therapeutics, Inc. (CVTX) |
April 17, 2009 |
1,000 |
| Sanofi-Aventis S.A. (SAN) |
Medley Pharmaceutical Industry SA |
April 27, 2009 |
680 |
| Stryker Corporation (SYK) |
Ascent Healthcare Solutions, Inc. |
December 31, 2009 |
525 |
| KP Chemical Corp. (064420) |
Pakistan PTA Limited (PPTA) |
September 18, 2009 |
500 |
| Thermo Fisher Scientific, Inc. (TMO) |
B R A H M S Aktiengesellschaft |
October 01, 2009 |
470 |
| Abbott Laboratories (ABT) |
Visiogen, Inc. |
October 20, 2009 |
400 |
^Top
Drugs under development
The following section shows a number of drugs either in clinical trials or awaiting FDA approval.
| Therapeutic Category | No.of Products | | Autoimmune & Inflammatory Diseases (Allergy, Graft Versus Host Disease, Lupus, Rheumatoid Arthritis...) | 1,122 | | Blood and Lymphatic Diseases (Anemia, Hemophilia, Thrombocythaemia...) | 353 | | Cardiovascular & Circulatory Disorders (Congestive Heart Failure, Angina Pectoris, Atherosclerosis...) | 785 | | Cancer (Leukemia, Colorectal Cancer, Small Cell Lung Cancer, Melanoma...) | 5,492 | | Central Nervous System (Alzheimer's Disease, Parkinson's Disease, Depression, epilepsy...) | 2,084 | | Dental (Caries, Dental Implant Systems, Dental Pain...) | 38 | | Dermatology (Psoriasis, Acne, Diabetic Ulcers...) | 513 | | Digestive System ( Duodenal Ulcer, Gastroesophageal Reflux Disease, Ulcerative Colitis...) | 509 | | Genetic Diseases (Gaucher's Disease, Mucopolysaccharidosis-I, Turner's Syndrome...) | 69 | | Infections (AIDS/HIV, Bacterial Infections,Hepatitis...) | 1,864 | | Kidneys & Genito-Urinary System (Urinary Incontinence, Nephritis,Erectile Dysfunction...) | 311 | | Metabolic/Endocrinology Disorders (Diabetes, Growth Hormone Deficiency, Acromegaly...) | 1,017 | | Musculoskeletal Disorders (Bone Diseases, Muscle Pain, Osteopetrosis...) | 351 | | Ophthalmology (Cataract, Choroidal Neovascularization (CNV), CMV Retinitis...) | 495 | | Respiratory Disorders (Asthma, Chronic Obstructive Pulmonary Disease, Respiratory Syncytial Virus (RSV) Infection...) | 704 | | Substance Abuse (Alcoholism, Drug Abuse, Methanol Poisoning, Smoking Cessation...) | 77 | | Women's Health (Ovarian Cancer, Breast Cancer, Endometriosis, Menopausal Symptoms...) | 242 | ^Top
|
|
|
|
|
|
 |
|
MedTRACK's Mission
To serve the pharmaceutical, biotechnology and financial industries and their supporting
vendors with high-quality, comprehensive corporate intelligence on biomedical companies
around the world.
|
|
 | |
 |
|
|
